Cargando…

The Role of Ergosterol and Sphingolipids in the Localization and Activity of Candida albicans’ Multidrug Transporter Cdr1p and Plasma Membrane ATPase Pma1p

Opportunistic pathogen Candida albicans causes systemic infections named candidiasis. Due to the increasing number of multi-drug resistant clinical isolates of Candida sp., currently employed antifungals (e.g., azoles) are insufficient for combating fungal infection. One of the resistance mechanisms...

Descripción completa

Detalles Bibliográficos
Autores principales: Urbanek, Aneta K., Muraszko, Jakub, Derkacz, Daria, Łukaszewicz, Marcin, Bernat, Przemysław, Krasowska, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9456455/
https://www.ncbi.nlm.nih.gov/pubmed/36077373
http://dx.doi.org/10.3390/ijms23179975
_version_ 1784785819706327040
author Urbanek, Aneta K.
Muraszko, Jakub
Derkacz, Daria
Łukaszewicz, Marcin
Bernat, Przemysław
Krasowska, Anna
author_facet Urbanek, Aneta K.
Muraszko, Jakub
Derkacz, Daria
Łukaszewicz, Marcin
Bernat, Przemysław
Krasowska, Anna
author_sort Urbanek, Aneta K.
collection PubMed
description Opportunistic pathogen Candida albicans causes systemic infections named candidiasis. Due to the increasing number of multi-drug resistant clinical isolates of Candida sp., currently employed antifungals (e.g., azoles) are insufficient for combating fungal infection. One of the resistance mechanisms toward azoles is increased expression of plasma membrane (PM) transporters (e.g., Cdr1p), and such an effect was observed in C. albicans clinical isolates. At the same time, it has been proven that a decrease in PMs sphingolipids (SLs) content correlates with altered sensitivity to azoles and diminished Cdr1p levels. This indicates an important role for SL in maintaining the properties of PM and gaining resistance to antifungal agents. Here, we prove using a novel spot variation fluorescence correlation spectroscopy (svFCS) technique that CaCdr1p localizes in detergent resistant microdomains (DRMs). Immunoblot analysis confirmed the localization of CaCdr1p in DRMs fraction in both the C. albicans WT and erg11Δ/Δ strains after 14 and 24 h of culture. We also show that the C. albicans erg11Δ/Δ strain is more sensitive to the inhibitor of SLs synthesis; aureobasidin A (AbA). AbA treatment leads to a diminished amount of SLs in C. albicans WT and erg11Δ/Δ PM, while, for C. albicans erg11Δ/Δ, the general levels of mannose-inositol-P-ceramide and inositol-P-ceramide are significantly lower than for the C. albicans WT strain. Simultaneously, the level of ergosterol in the C. albicans WT strain after adding of AbA remains unchanged, compared to the control conditions. Analysis of PM permeabilization revealed that treatment with AbA correlates with the disruption of PM integrity in C. albicans erg11Δ/Δ but not in the C. albicans WT strain. Additionally, in the C. albicans WT strain, we observed lower activity of H(+)-ATPase, correlated with the delocalization of both CaCdr1p and CaPma1p.
format Online
Article
Text
id pubmed-9456455
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-94564552022-09-09 The Role of Ergosterol and Sphingolipids in the Localization and Activity of Candida albicans’ Multidrug Transporter Cdr1p and Plasma Membrane ATPase Pma1p Urbanek, Aneta K. Muraszko, Jakub Derkacz, Daria Łukaszewicz, Marcin Bernat, Przemysław Krasowska, Anna Int J Mol Sci Article Opportunistic pathogen Candida albicans causes systemic infections named candidiasis. Due to the increasing number of multi-drug resistant clinical isolates of Candida sp., currently employed antifungals (e.g., azoles) are insufficient for combating fungal infection. One of the resistance mechanisms toward azoles is increased expression of plasma membrane (PM) transporters (e.g., Cdr1p), and such an effect was observed in C. albicans clinical isolates. At the same time, it has been proven that a decrease in PMs sphingolipids (SLs) content correlates with altered sensitivity to azoles and diminished Cdr1p levels. This indicates an important role for SL in maintaining the properties of PM and gaining resistance to antifungal agents. Here, we prove using a novel spot variation fluorescence correlation spectroscopy (svFCS) technique that CaCdr1p localizes in detergent resistant microdomains (DRMs). Immunoblot analysis confirmed the localization of CaCdr1p in DRMs fraction in both the C. albicans WT and erg11Δ/Δ strains after 14 and 24 h of culture. We also show that the C. albicans erg11Δ/Δ strain is more sensitive to the inhibitor of SLs synthesis; aureobasidin A (AbA). AbA treatment leads to a diminished amount of SLs in C. albicans WT and erg11Δ/Δ PM, while, for C. albicans erg11Δ/Δ, the general levels of mannose-inositol-P-ceramide and inositol-P-ceramide are significantly lower than for the C. albicans WT strain. Simultaneously, the level of ergosterol in the C. albicans WT strain after adding of AbA remains unchanged, compared to the control conditions. Analysis of PM permeabilization revealed that treatment with AbA correlates with the disruption of PM integrity in C. albicans erg11Δ/Δ but not in the C. albicans WT strain. Additionally, in the C. albicans WT strain, we observed lower activity of H(+)-ATPase, correlated with the delocalization of both CaCdr1p and CaPma1p. MDPI 2022-09-01 /pmc/articles/PMC9456455/ /pubmed/36077373 http://dx.doi.org/10.3390/ijms23179975 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Urbanek, Aneta K.
Muraszko, Jakub
Derkacz, Daria
Łukaszewicz, Marcin
Bernat, Przemysław
Krasowska, Anna
The Role of Ergosterol and Sphingolipids in the Localization and Activity of Candida albicans’ Multidrug Transporter Cdr1p and Plasma Membrane ATPase Pma1p
title The Role of Ergosterol and Sphingolipids in the Localization and Activity of Candida albicans’ Multidrug Transporter Cdr1p and Plasma Membrane ATPase Pma1p
title_full The Role of Ergosterol and Sphingolipids in the Localization and Activity of Candida albicans’ Multidrug Transporter Cdr1p and Plasma Membrane ATPase Pma1p
title_fullStr The Role of Ergosterol and Sphingolipids in the Localization and Activity of Candida albicans’ Multidrug Transporter Cdr1p and Plasma Membrane ATPase Pma1p
title_full_unstemmed The Role of Ergosterol and Sphingolipids in the Localization and Activity of Candida albicans’ Multidrug Transporter Cdr1p and Plasma Membrane ATPase Pma1p
title_short The Role of Ergosterol and Sphingolipids in the Localization and Activity of Candida albicans’ Multidrug Transporter Cdr1p and Plasma Membrane ATPase Pma1p
title_sort role of ergosterol and sphingolipids in the localization and activity of candida albicans’ multidrug transporter cdr1p and plasma membrane atpase pma1p
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9456455/
https://www.ncbi.nlm.nih.gov/pubmed/36077373
http://dx.doi.org/10.3390/ijms23179975
work_keys_str_mv AT urbanekanetak theroleofergosterolandsphingolipidsinthelocalizationandactivityofcandidaalbicansmultidrugtransportercdr1pandplasmamembraneatpasepma1p
AT muraszkojakub theroleofergosterolandsphingolipidsinthelocalizationandactivityofcandidaalbicansmultidrugtransportercdr1pandplasmamembraneatpasepma1p
AT derkaczdaria theroleofergosterolandsphingolipidsinthelocalizationandactivityofcandidaalbicansmultidrugtransportercdr1pandplasmamembraneatpasepma1p
AT łukaszewiczmarcin theroleofergosterolandsphingolipidsinthelocalizationandactivityofcandidaalbicansmultidrugtransportercdr1pandplasmamembraneatpasepma1p
AT bernatprzemysław theroleofergosterolandsphingolipidsinthelocalizationandactivityofcandidaalbicansmultidrugtransportercdr1pandplasmamembraneatpasepma1p
AT krasowskaanna theroleofergosterolandsphingolipidsinthelocalizationandactivityofcandidaalbicansmultidrugtransportercdr1pandplasmamembraneatpasepma1p
AT urbanekanetak roleofergosterolandsphingolipidsinthelocalizationandactivityofcandidaalbicansmultidrugtransportercdr1pandplasmamembraneatpasepma1p
AT muraszkojakub roleofergosterolandsphingolipidsinthelocalizationandactivityofcandidaalbicansmultidrugtransportercdr1pandplasmamembraneatpasepma1p
AT derkaczdaria roleofergosterolandsphingolipidsinthelocalizationandactivityofcandidaalbicansmultidrugtransportercdr1pandplasmamembraneatpasepma1p
AT łukaszewiczmarcin roleofergosterolandsphingolipidsinthelocalizationandactivityofcandidaalbicansmultidrugtransportercdr1pandplasmamembraneatpasepma1p
AT bernatprzemysław roleofergosterolandsphingolipidsinthelocalizationandactivityofcandidaalbicansmultidrugtransportercdr1pandplasmamembraneatpasepma1p
AT krasowskaanna roleofergosterolandsphingolipidsinthelocalizationandactivityofcandidaalbicansmultidrugtransportercdr1pandplasmamembraneatpasepma1p